Clonidine
Rank #456 of 500 drugs by total cost
Data: CMS Medicare Part D, 2023 (most current available) · Updated March 2026
$16.7M
Total Cost
112,710
Total Claims
$16.7M
Total Cost
5,268
Prescribers
$148
Cost per Claim
5,256
Beneficiaries
157,521
30-Day Fills
$3,166
Avg Cost/Provider
21
Avg Claims/Provider
Share of Medicare Part D Spending
0.01%
of total Medicare Part D spending
$16.7M of $275.65B
Top Prescribers by Cost
Top 10 prescribers of $16.7M total
Top Prescribers of Clonidine
| # | Provider | Specialty | Location | Claims | Cost |
|---|---|---|---|---|---|
| 1 | Shashi Sharma | Cardiology | Visalia, CA | 231 | $57K |
| 2 | Paramjit Takhar | Family Practice | Sacramento, CA | 166 | $45K |
| 3 | Grigoriy Goldenberg | Internal Medicine | Brooklyn, NY | 482 | $43K |
| 4 | James Parks | Cardiology | Birmingham, AL | 258 | $41K |
| 5 | Steven Clark | Internal Medicine | Cleveland, MS | 301 | $39K |
| 6 | Ricardo Cigarroa | Interventional Cardiology | Laredo, TX | 255 | $38K |
| 7 | Hajir Dilmanian | Nuclear Medicine | Brooklyn, NY | 95 | $37K |
| 8 | Fernando Segovia | Interventional Cardiology | Edgewater, NJ | 199 | $37K |
| 9 | Kevin Scott | Family Practice | Wyncote, PA | 136 | $30K |
| 10 | Uri Ben-Zur | Cardiology | Tarzana, CA | 210 | $29K |
| 11 | Vivienne Smith | Cardiology | Albany, NY | 286 | $27K |
| 12 | Ashraf Nashed | Cardiology | Thousand Oaks, CA | 165 | $27K |
| 13 | Don Lee | Interventional Cardiology | Glendale, CA | 246 | $27K |
| 14 | Raffi Minasian | Nephrology | Glendale, CA | 140 | $26K |
| 15 | Vivek Khetpal | Cardiology | Durant, OK | 106 | $25K |
Top prescribers ranked by total cost for this drug in 2023.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 453 | Dicyclomine Hcl (Dicyclomine Hcl) | $17.0M | 738,543 |
| 454 | Nitroglycerin (Nitroglycerin) | $16.8M | 768,384 |
| 455 | Lanreotide Acetate (Somatuline Depot) | $16.7M | 1,753 |
| 456 | Clonidine (Clonidine) | $16.7M | 112,710 |
| 457 | Glucagon (Gvoke Hypopen 2-Pack) | $16.6M | 31,523 |
| 458 | Bosentan (Bosentan) | $16.5M | 2,765 |
| 459 | Telmisartan (Telmisartan) | $16.4M | 334,601 |
Related Analysis
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology